Clinical Trial Update: A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of VG-3927 conducted in healthy adults and patients with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• VG-3927

Snippet

Sponsor: Vigil Neuroscience, Inc. | Conditions: Healthy, Alzheimer Disease | Phase 1 | Status: COMPLETED